ArticleslgStudy

chemistry

Treprostinil

Treprostinil is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Treprostinil rather than just read about it. In short: Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil was approved for use in the United States in May 2002.

Treprostinil — main illustration
Treprostinil — illustration

Key takeaways

  • Treprostinil belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Treprostinil to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Treprostinil from memory before moving on to harder problems.

Reference excerpt

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil was approved for use in the United States in May 2002.

Medical uses Treprostinil is indicated for the treatment of pulmonary arterial hypertension in people with NYHA Class II-IV symptoms to diminish symptoms associated with exercise. Treprostinil inhalation solution and treprostinil inhalation powder are indicated for the treatment of people with pulmonary arterial hypertension (WHO Group 1) to improve exercise ability; and people with pulmonary hypertension associated with interstitial lung disease (WHO Group 3) to improve exercise ability. In the European Union, treprostinil (Trepulmix) is indicated for the treatment of adults with WHO Functional Class III or IV and inoperable chronic thromboembolic pulmonary hypertension; or persistent or recurrent chronic thromboembolic pulmonary hypertension after surgical treatment to improve exercise capacity.

Adverse effects Since treprostinil is a vasodilator, its antihypertensive effect may be compounded by other medications that affect the blood pressure, including calcium channel blockers, diuretics, and other vasodilating agents. Because of treprostinil's inhibiting effect on platelet aggregation, there is an increased risk of bleeding, especially among patients who are also taking anticoagulants. Common side effects depending on route of administration:

85% of patients report pain or other reaction at the infusion site.

History

In 1976, the first paper on prostacyclin was published. Treprostinil (Remodulin) was approved for medical use in the United States in May 2002, and again in July 2018. Treprostinil (Tyvaso), as inhalation solution, was approved for medical use in the United States in July 2009, and again in April 2021. Treprostinil (Orenitram), as extended release tablets, was approved for medical use in the United States in December 2013. Treprostinil (Trepulmix) was authorized for medical use in the European Union in April 2020. Trepulmix is a hybrid medicine that is similar to the reference medicine Remodulin. It contains the same active substance, but it is used for treating a different form of pulmonary hypertension. Treprostinil (Tyvaso DPI), as inhalation powder, was approved for medical use in the United States in May 2022. Treprostinil (Yutrepia), as inhalation powder, was approved for medical use in the United States in June 2025.

Research Treprostinil therapy may be effective in treating Degos disease.

References

Further reading Narine L, Hague LK, Walker JH, Vicente C, Schilz R, Desjardins O, et al. (December 2005). "Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension". Current Medical Research and Opinion. 21 (12): 2007–2016. doi:10.1185/030079905X75104. PMID 16368052. S2CID 13162585.

External links "Treprostinil Oral Inhalation: MedlinePlus Drug Information". MedlinePlus. "Treprostinil: MedlinePlus Drug Information". MedlinePlus. Clinical trial number NCT03399604 for "Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil (INSPIRE)" at ClinicalTrials.gov

Illustrations

Treprostinil illustration
Treprostinil illustration

Worked examples

Example 1 — a first encounter with Treprostinil

Start with the simplest possible case. Write down what Treprostinil claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Treprostinil before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Treprostinil ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Treprostinil

In research
Treprostinil appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Treprostinil in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Treprostinil is common in secondary-school and first-year university syllabi. It links to neighbouring topics Acetic acids, Orphan drugs, Phenol ethers, so understanding it makes those chapters shorter.
In everyday life
Look for Treprostinil outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Treprostinil in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Treprostinil means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Treprostinil out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Treprostinil in simple terms?

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil was approved for use in the United States in May 2002.

Why does Treprostinil matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Treprostinil?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Treprostinil.

Tags

  • Acetic acids
  • Orphan drugs
  • Phenol ethers
  • Prostaglandins
  • Secondary alcohols

Keep exploring